Elisei Rossella, Bottici Valeria, Luchetti Fabiana, Di Coscio Giancarlo, Romei Cristina, Grasso Lucia, Miccoli Paolo, Iacconi Pietro, Basolo Fulvio, Pinchera Aldo, Pacini Furio
Department of Endocrinology and Metabolism, University of Pisa, 56124 Pisa, Italy.
J Clin Endocrinol Metab. 2004 Jan;89(1):163-8. doi: 10.1210/jc.2003-030550.
The survival rate of patients with medullary thyroid carcinoma (MTC) is significantly better in patients diagnosed and treated when the tumor is limited to the thyroid. In a pioneer study carried out in 1991, we demonstrated that routine measurement of serum calcitonin (CT) in nodular thyroid disease allowed the preoperative diagnosis of unsuspected sporadic MTC with better accuracy than routine fine needle aspiration cytology (FNAC). This finding has been confirmed in subsequent studies. In the present study we report the results of CT screening in 10,864 patients with thyroid nodular disease seen in the years 1991-1998 (group 1). We analyzed the prevalence of MTC and compared their outcomes with those of a historical group of patients (group 2) diagnosed before the introduction of CT screening (1970-1990). The prevalence of MTC found by CT screening in group 1 was 0.40% (44 patients). A positive CT test had a higher diagnostic sensitivity and specificity compared with FNAC. CT screening allowed the diagnosis of MTC at an earlier stage compared with group 2 (P = 0.004). Normalization of serum CT levels (undetectable) after surgery was more frequently observed in group 1. At the end of follow-up, complete remission was observed in 59% of group 1 and in 2.7% of group 2 (P = 0.0001). Our study confirms that MTC is not an infrequent finding among patients with thyroid nodules (nearly 1 in 250 patients). In addition, screening thyroid nodules with serum CT measurement allows the diagnosis and treatment of MTC at an earlier stage, resulting in a better outcome compared with MTC not detected by serum CT measurement. One of the reasons for this finding is that increasing the preoperative diagnostic accuracy of MTC prompts the surgeon to perform a more radical and possibly curative treatment. On this basis, routine measurement of basal serum CT levels should be considered an integral part of the diagnostic evaluation of thyroid nodules.
甲状腺髓样癌(MTC)患者在肿瘤局限于甲状腺时被诊断和治疗,其生存率显著更高。在1991年进行的一项开创性研究中,我们证明,在结节性甲状腺疾病中常规检测血清降钙素(CT),能够比常规细针穿刺细胞学检查(FNAC)更准确地对未被怀疑的散发性MTC进行术前诊断。这一发现已在后续研究中得到证实。在本研究中,我们报告了1991年至1998年期间对10864例甲状腺结节性疾病患者进行CT筛查的结果(第1组)。我们分析了MTC的患病率,并将其结果与CT筛查引入之前(1970年至1990年)诊断的一组历史患者(第2组)的结果进行了比较。第1组通过CT筛查发现的MTC患病率为0.40%(44例患者)。与FNAC相比,CT检测呈阳性具有更高的诊断敏感性和特异性。与第2组相比,CT筛查使MTC在更早阶段得到诊断(P = 0.004)。第1组术后血清CT水平正常化(检测不到)的情况更常见。随访结束时,第1组59%的患者实现完全缓解,第2组为2.7%(P = 0.0001)。我们的研究证实,MTC在甲状腺结节患者中并不罕见(近250名患者中有1例)。此外,通过检测血清CT筛查甲状腺结节能够在更早阶段诊断和治疗MTC,与未通过血清CT检测发现的MTC相比,结果更好。这一发现的原因之一是,提高MTC术前诊断准确性促使外科医生进行更彻底且可能治愈性的治疗。在此基础上,常规检测基础血清CT水平应被视为甲状腺结节诊断评估的一个组成部分。